Ganga Pharmaceuticals Ltd.
| BSE: 539680 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE615T01017 |
| BSE 00:00 | 02 Feb | Ganga Pharmaceuticals Ltd |
| NSE 05:30 | 01 Jan | Ganga Pharmaceuticals Ltd |
| OPEN | 7.50 |
| PREVIOUS CLOSE | 7.50 |
| VOLUME | 8000 |
| 52-Week high | 12.00 |
| 52-Week low | 7.50 |
| P/E | 16.30 |
| Mkt Cap.(Rs cr) | 3 |
| Buy Price | 8.64 |
| Buy Qty | 8000.00 |
| Sell Price | 9.00 |
| Sell Qty | 8000.00 |
Ganga Pharmaceuticals Ltd. (GANGAPHARMA) - Announcements
-
Ganga Pharmaceuticals Ltd Compliance Certificate Under Regulation 7(3) Of LODR For The Half Year Ended March 31 2021
30/04/2021 | bse |
Downlaod PDF -
Ganga Pharmaceuticals Ltd Format of Initial Disclosure to be made by an entity identified as a Large Corporate
29/04/2021 | bse |
Downlaod PDF -
Ganga Pharmaceuticals Ltd Submission Of Certificate Under Clause 40(10) Of SEBI (LODR) Regulation 2015 For The Half Year Ended
26/04/2021 | bse |
Downlaod PDF -
Ganga Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
26/04/2021 | bse |
Downlaod PDF -
Ganga Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended March 2021
14/04/2021 | bse
-
Ganga Pharmaceuticals Ltd Shareholding for the Period Ended March 31 2021
12/04/2021 | bse
-
Ganga Pharmaceuticals Ltd Closure of Trading Window
31/03/2021 | bse |
Downlaod PDF -
Ganga Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
16/01/2021 | bse |
Downlaod PDF -
Ganga Pharmaceuticals Ltd Shareholding for the Period Ended December 31 2020
08/01/2021 | bse
-
Ganga Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended December 2020
06/01/2021 | bse
-
Ganga Pharmaceuticals Ltd Submission Of Half Yearly Disclosure On Related Party Transaction
04/12/2020 | bse |
Downlaod PDF -
Ganga Pharmaceuticals Ltd Outcome Of Board Meeting Held Today I.E. November 5 2020
05/11/2020 | bse |
Downlaod PDF -
Ganga Pharmaceuticals Ltd Submission Of Compliance Certificate Pursuant To Regulation 40(10) Of The SEBI (Listing Obligations
29/10/2020 | bse |
Downlaod PDF -
Ganga Pharmaceuticals Ltd Compliance Certificate Under Regulation 7(3) Of LODR For The Half Year Ended September 30 2020
29/10/2020 | bse |
Downlaod PDF -
Ganga Pharmaceuticals Ltd Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Compan
27/10/2020 | bse |
Downlaod PDF -
Ganga Pharmaceuticals Ltd Shareholding for the Period Ended September 30 2020
15/10/2020 | bse
-
Ganga Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
15/10/2020 | bse |
Downlaod PDF -
Ganga Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended September 2020
15/10/2020 | bse
-
Ganga Pharmaceuticals Ltd Closure of Trading Window
30/09/2020 | bse |
Downlaod PDF -
Ganga Pharmaceuticals Ltd Shareholder Meeting / Postal Ballot-Scrutinizers Report
26/09/2020 | bse |
Downlaod PDF
Quick Links for Ganga Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
